A recent breakthrough finding that Paneth cell specific peptide “Human alpha-defensin 5 (DEFA5)” delineate colonic IBD (CC versus UC) may solve diagnostic dilemma in IBD clinical settings [265]. The gene discussed is DEFA5; the disease is inflammatory bowel disease.